Quick Order Cart

Cat. No. ARG38076

ANKS6 Knockout HEK293T Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Kidney

The ANKS6 Knockout HEK293T Polyclonal Cells provide a CRISPR/Cas9-edited polyclonal knockout population targeting ANKS6, a ciliary transition zone protein that negatively regulates cystogenesis. In HEK293T human embryonic kidney cells, ANKS6 disruption impairs its complex formation with NPHP3, INVS, and NEK8, leading to dysregulated Wnt/??-catenin and Hippo/YAP-TAZ signaling and planar cell polarity defects. This model is applicable for studying nephronophthisis pathology, ciliary signaling crosstalk, and cystic kidney disease mechanisms. Key research uses include immunoblotting, immunofluorescence for ciliary markers, 3D cyst assays, and drug testing against aberrant YAP/TAZ or ??-catenin activity.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HEK293T

    Sex of Donor

    Female

    Age

    Fetus

    Derived From Site

    Fetal kidney

    Gene Name

    ANKS6

    Gene Identifier

    NCBI Gene ID 203286

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    DMEM

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The ANKS6 Knockout HEK293T Polyclonal Cells consist of a CRISPR/Cas9-edited polyclonal population with targeted gene disruption at the ANKS6 locus. As polyclonal knockout cells, this product offers a genetically diverse loss-of-function model without the biases associated with single-cell cloning, allowing assessment of gene-dosage effects and population-level phenotypic variation. Derived from Homo sapiens, these cells provide a versatile platform for studying the ciliary protein ANKS6 in an immortalized cell background.

HEK293T cells are human embryonic kidney epithelial cells immortalized by adenoviral E1A and E1B gene expression and further engineered to harbor the SV40 large T antigen. This modification supports high-copy episomal replication of transfected plasmids, enabling efficient protein overexpression, lentivirus production, and transient gene silencing or expression studies. The adherent epithelial morphology and rapid doubling time of HEK293T facilitate routine culture and high-throughput screening, while their renal origin maintains baseline expression of many kidney-related genes, providing contextual relevance for ciliopathy research.

ANKS6 (Ankyrin Repeat and SAM Domain-Containing Protein 6) is an essential component of the ciliary transition zone, where it assembles into a supramolecular complex with NPHP3, INVS, and NEK8 to negatively regulate kidney cystogenesis. This complex functions downstream of ciliary signaling inputs, including those from primary cilia deflection and Wnt ligand stimulation, and is transcriptionally regulated by RFX factors. Loss of ANKS6 disrupts ciliary homeostasis, leading to aberrant activation of both canonical Wnt/??-catenin and Hippo/YAP-TAZ pathways, with ??-catenin stabilization and YAP/TAZ nuclear accumulation driving deregulated epithelial proliferation and planar cell polarity defects. Interactors such as ANKS3 and intraflagellar transport proteins further underscore its nodal role in ciliary signal integration.

Within HEK293T cells, ANKS6 knockout creates a tractable system for investigating ciliary protein function and downstream signaling cascades. Although HEK293T normally grow as monolayers, they can be adapted to three-dimensional culture conditions that promote partial polarization and lumen formation, serving as a surrogate for kidney tubular morphogenesis. The polyclonal knockout pool is particularly suited for examining population heterogeneity in Wnt and Hippo pathway responses, as variable residual ANKS6 expression across the population may mimic heterozygous states encountered in human nephronophthisis.

This knockout model supports diverse applications such as western blotting and RT-qPCR for quantifying Wnt/Hippo target gene expression, immunofluorescence for ciliary markers, and co-immunoprecipitation to probe altered protein interaction networks. Furthermore, 3D cyst growth assays and cell proliferation analyses enable functional evaluation of cystogenic potential and candidate drug screening for cystic kidney diseases including nephronophthisis type 16. For further technical details, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)